Omni Peptides

SS-31

Dhs. 1,100.00 AED

Sale Sold out

VIAL

Freeze-dried powder in a sealed glass vial. Reconstitute with bacteriostatic water and administer via syringe. The most versatile and cost-effective research format.

RECONSTITUTION & SYRINGE REQUIRED

CARTRIDGE

Pre-filled and ready to administer. Slides into a reusable pen injector — no measuring or mixing required. Clean, discreet, and consistent across research protocols.

REQUIRES COMPATIBLE PEN INJECTOR

NASAL

Delivered via mucosal absorption — no needles required. A popular choice for research protocols where needle-free administration is preferred.

NEEDLE-FREE — SPRAY & GO

PEN

An all-in-one auto-injector with the cartridge pre-loaded. Dial, click, and administer. Optimal for high-frequency research protocols requiring precise, repeatable dosing.

DIAL, CLICK & INJECT — NO PREP

Vials are freeze-dried (lyophilised) powder — kept refrigerated unopened, they remain stable for up to 2 years.

Cartridges, nasal sprays, and pens arrive pre-filled as liquid, must be kept refrigerated at all times, and carry a Beyond Use Date — typically 4–8 weeks from receipt. Please refer to the BUD on the label.

Size 10mg 50mg

Mitochondria-repair peptide; energy, endurance, neuroprotection, anti-aging at cellular level

SS-31 (also known as Elamipretide, Bendavia, or MTP-131) is a synthetic tetrapeptide designed as a mitochondria-targeted antioxidant from the Szeto-Schiller (SS) series. This research compound selectively accumulates in the inner mitochondrial membrane by binding to cardiolipin, a phospholipid critical for electron transport chain organization. It has garnered extensive scientific interest for its ability to scavenge reactive oxygen species (ROS), stabilize mitochondrial structure, enhance ATP production, and reduce oxidative damage without relying on mitochondrial membrane potential. Researchers employ SS-31 in laboratory and animal models to investigate mitochondrial dysfunction in aging, neurodegeneration, cardiovascular disorders, renal injury, and other conditions linked to bioenergetic failure. As a research-grade compound, SS-31 is intended exclusively for in vitro and animal studies. Scientists value its remarkable cell permeability, high mitochondrial selectivity, and potential to elucidate cardiolipin-mediated mitochondrial protection mechanisms. (Note: Elamipretide has received regulatory approval for specific clinical indications such as Barth syndrome in some jurisdictions, but research formulations remain designated for laboratory use.)

Molecular Formula

C₃₂H₄₉N₉O₅

Molecular Weight

639.8 g/mol

Sequence

D-Arg-Dmt-Lys-Phe-NH₂ (where Dmt = 2',6'-dimethyltyrosine; amidated C-terminus)

Research Applications

Mitochondrial Protection and Bioenergetics
Preclinical studies demonstrate that SS-31 binds cardiolipin to optimize electron transport chain supercomplex assembly, improve oxidative phosphorylation coupling, increase ATP synthesis, and reduce ROS production in dysfunctional mitochondria across various models.
Aging and Age-Related Decline
Investigations show SS-31 reverses age-related redox stress, restores mitochondrial function in skeletal muscle and other tissues, improves exercise tolerance, and mitigates sarcopenia-like phenotypes in aged animal models.
Neuroprotection and CNS Disorders
SS-31 exhibits potent effects in models of Alzheimer's disease, ischemic brain injury, traumatic brain injury, and neurodegeneration by reducing Aβ production, preserving mitochondrial dynamics, inhibiting apoptosis, and protecting neural tissues from oxidative insults.
Cardiovascular and Renal Protection
Research highlights its role in ameliorating ischemia-reperfusion injury, improving cardiac mitochondrial morphology (e.g., in Barth syndrome models), reducing glomerular damage in aged kidneys, and accelerating ATP recovery in ischemic tissues.
Broader Tissue and Organ Protection
Studies indicate benefits in reducing oxidative stress and inflammation in models of wound healing, liver injury, ophthalmic conditions, and other pathologies involving mitochondrial impairment, while promoting cellular resilience and repair.

Storage & Handling

Lyophilised vials are stable at −20°C for up to 2 years unopened. Once reconstituted, refrigerate at 2–8°C and use within 28 days. Avoid repeated freeze-thaw cycles.

Beyond Use Date

Pre-filled formats (cartridge, pen, nasal) carry a beyond-use date of typically 4–8 weeks from receipt. ≥98% purity by HPLC. For in vitro and preclinical research use only — not for human or veterinary use.